Fiera Capital (Canada)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Fiera Capital (Canada)’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-18,320	Closed	-$298K	–	699
2017 Q1	$298K	Hold	18,320	–	–	﹤0.01%	572
2016 Q4	$276K	Hold	18,320	–	–	﹤0.01%	700
2016 Q3	$279K	Hold	18,320	–	–	﹤0.01%	660
2016 Q2	$711K	Hold	18,320	–	–	﹤0.01%	605
2016 Q1	$509K	Hold	18,320	–	–	﹤0.01%	477
2015 Q4	$985K	Hold	18,320	–	–	0.01%	428
2015 Q3	$734K	Hold	18,320	–	–	0.01%	402
2015 Q2	$585K	Buy	+18,320	New	+$465K	﹤0.01%	429

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Fiera Capital (Canada)'s ITCI Position: Q2 2017 in Review

Fiera Capital (Canada) sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2017, closing a stake of 18,320 shares — an estimated $298K sold.

Fiera Capital (Canada) first reported a position in ITCI in Q2 2015 and held it in 8 quarters. The position peaked at $985K in Q4 2015. 100 funds tracked by Wall St. Rank hold ITCI as of Q2 2017.

Fiera Capital (Canada) reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2017 after selling out during the quarter.
Fiera Capital (Canada) sold 18,320 Intra-Cellular Therapies Inc. shares in Q2 2017, an estimated $298K.
Fiera Capital (Canada) first reported a position in Intra-Cellular Therapies Inc. in Q2 2015 and held it in 8 quarters.
Fiera Capital (Canada)'s Intra-Cellular Therapies Inc. position peaked at $985K in Q4 2015.
100 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2017, filed 10 Aug 2017.